Skip to content

Biological Age in Health Promotion - Novel Health Technology

Development of a New Biological Age Technology Applicable in Public Health Promotion Interventions.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03680768
Acronym
BATE
Enrollment
100
Registered
2018-09-21
Start date
2018-10-09
Completion date
2019-12-20
Last updated
2020-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Healthy

Keywords

Health, Risk of disease, Prediction, Lifestyle

Brief summary

The purpose of this cross-sectional study is to collect relevant molecular markers of aging and measures of physiological function. Together these biomarkers are used to develope a new Biological Age model, useful in health promotion interventions in the public health sector .

Detailed description

Study design: 100 participants representing the healthy danish working adult population. This study seek to include both men and women equally distributed in the range of 18-65 of age. Data collection: After recruitment, participants need to attend once to the laboratory, overnight fasted and without having exercised for the previous 24 hours. All analyse are done in investigators lab (Xlab) at the department of Biomedical Sciences, Copenhagen University. When analyzes are done, the results are used in algorithm developement in cooperation with Technical university Denmark.

Interventions

The protocol includes measurements of body composition, strength test, functional and fitness test as well as biochemical measurements from blood samples and AGEreader

Sponsors

Technical University of Denmark
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females interested in their personal health status * Healthy males and females

Exclusion criteria

* Pregnancy * Previous or current cardiovascular disease * Use of medication that affects our measurements such as betablockers,statins or medication that affects the metabolism.

Design outcomes

Primary

MeasureTime frameDescription
Biological AgeDay 1A composite score of ones biological state (in years)

Secondary

MeasureTime frameDescription
StrengthDay 0Hand grip, isometric quadriceps and biceps strength (Nm)
Sit to Stand testDay 0Rise and sit from a chair as many times as possible during 1 minute (number og rises)
Central obesityDay 0Waist to hip ratio is measured by dividing waist circumference with hip circumference in cm.
WeightDay 0measured in kilograms
HeightDay 0measured in cm
Body compositionDay 0BMI (kg/m2) is calculated
Muscle massDay 0muscle mass(g) is assessed by dual energy x-ray absorptiometry (DXA) and bioimpedance
Fat massDay 0fat mass(g) is assessed by DXA and bioimpedance
Fat percentageDay 0Fat%, is assessed by DXA and bioimpedance
Lipid profileDay 0HighDensityLipoprotein (mmol/L), LowDensityLipoprofile (mmol/L), TriGlycerides (mmol/L), FreeFattyAcids (mmol/L) and Glycerol (mmol/L) is measured in a blood sample.
Fitness LevelDay 0VO2max - maximal oxygen consumption (ml/min/kg)
Inflammatory profileDay 0C-reactive protein mg/L, soluble urokinase plasminogen activating receptor ng/ml, InterLeukin 6,8 and 10 (pg/mL), tumor necrosis factor (pg/mL), Leptin and Adiponectin (ng/ml) is analysed from blood samples
Levels of glycated protein and lipids as a result of exposure of excess sugarsDay 0advanced glycation endproducts (AGE) measured in the skin
Color passport photographyDay 0Profile picture taken to assess perceived age
RespirometryDay 0forced vital capacity and forced expiratory volume at one second(L)
Blood PressureDay 0Systolic and Diastolic blood pressure (mmHg)
Blood glucoseDay 0HbA1c and fasting glucose (mmol/L) measured from blood sample
Blood profileDay 0Haematocrit and Haemoglobin (mmol/L) measured in a blood sample
Aging biomarkerDay 0Chemokines Eotaxin (CCL11) analysed from blood samples
Youth biomarkerDay 0Growth Differential Factor (GDF-11) analysed from blood samples
HormonesDay 0Sex hormones: testosteron and estradiol (nmol/L) and InsulinGrowthFactor-1 (nmol/L) and Insulin (µU/ml) ais analysed from blood samples

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026